Skip to main content
Revista Española de Quimioterapia logoLink to Revista Española de Quimioterapia
. 2024 Jan 23;37(2):176–179. doi: 10.37201/req/116.2023

Is it in their eyes? Correlation between microorganisms isolated from bronchial aspirates and conjunctival swabs in a Pediatric Intensive Care Unit

¿Está en sus ojos? Correlación entre microorganismos aislados de aspirados bronquiales e hisopos conjuntivales en una Unidad de Cuidados Intensivos Pediátricos

Jorge Ligero-López 1, Luis Escosa-García 2,3, Cristina Schüffelmann-Gutiérrez 4, María Laplaza-González 2, María Inmaculada Quiles-Melero 1, Francisco Moreno-Ramos 5, Fernando Baquero-Artigao 2,3, Juana Cacho-Calvo 1, Emilio Cendejas-Bueno 1,3,
PMCID: PMC10945105  PMID: 38258553

Abstract

Objectives

Our observational, retrospective study aimed to determine the correlation between bacteria isolated from bronchial aspirates of pediatric ICU patients (PICU) with respiratory infections and those obtained from conjunctival swabs of the same patients exhibiting clinical conjunctivitis

Material and methods

Throughout the period from 2015 to 2022, we reviewed all clinically significant bronchial aspirates (≥105 CFU/mL) and positive conjunctival swabs obtained from PICU patients. These records were retrieved from the microbiology database, cross-referencing the data to identify patients who tested positive for both during the same clinical episode

Results

The median age of the patients was 5 months (interquartile range: 1-7). Among the cohort, twenty-one patients exhibited positivity in both bronchial aspirate and conjunctival swab samples, showcasing a microbial match in 85.71% of cases (18 out of 21). The most frequently isolated microorganisms were Haemophilus influenzae (55.6%), followed by Pseudomonas aeruginosa (14.3%), Klebsiella aerogenes (9.5%), and Escherichia coli, Stenotrophomonas maltophilia, and Enterobacter cloacae, each accounting for 4.8% of the isolates

Conclusions

Our study demonstrates a strong concordance between the isolated microorganisms from both samples in patients presenting clear symptoms of clinical conjunctivitis. These findings provide a basis for future prospective studies that may leverage conjunctival swabs as a predictive tool for identifying microorganisms involved in respiratory infections

Keywords: bronchial aspirate, conjunctival swab, respiratory bacterial superinfection

INTRODUCTION

Purulent conjunctivitis is a common infectious disease during childhood. The predominant pathogens of bacterial conjunctivitis in children are Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis [1]. Bacterial conjunctivitis is more common than the viral form in children. These microorganisms are normal inhabitants of the nasopharynx, especially in children, and can spread to other sites, including the eye, ear, and lower respiratory tract [2]

Respiratory syncytial virus (RSV) is a common cause of childhood pneumonia, and bacterial coinfections can affect clinical severity in those requiring Pediatric Intensive Care Unit (PICU). The prevalence of bacterial coinfections has been established in RSV-positive pneumonia [3]. Some studies have shown that co-detections are associated with longer need for mechanical ventilation and hospital stays. Almost one-third of the patients harbored bacterial pathogens [4], although other studies have detected a bacterial coinfection rate of 43.6% in hospitalized children using washed sputum culture [5]

Hospital-acquired respiratory infections are common in the intensive care unit (ICU). Hospital-acquired pneumonia (HAP), defined as occurring in patients with at least 48 hours of hospital admission, is highly prevalent in the ICU. The common pathogens associated with HAP include Enterobacterales, Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii. In 30% of cases, the infection is polymicrobial. Microbiological confirmation is a crucial step in the diagnosis of hospital respiratory infections. Routinely, diagnosis is based on qualitative or quantitative cultures of respiratory samples, and a pathogen is isolated from these samples and identified in about 70% of suspected cases [6]

The objective of this study is to ascertain whether a correlation exists between bacteria isolated from bronchial aspirates of patients infected in the respiratory tract and those isolated from conjunctival samples of these patients exhibiting clinically relevant conjunctivitis

MATERIAL AND METHODS

Throughout the study period, there were 7459 admissions to the PICU, with 1472 bronchial aspirates and 259 conjunctival swabs sent for microbiological culture. For this investigation, only positive and clinically significant (≥ 105CFU/mL) bronchial aspirates and conjunctival swabs were selected from the Microbiology department database, focusing on Pediatric Intensive Care Unit (PICU) patients between 2015 and 2022. Conjunctival swabs were exclusively obtained when clinical conjunctivitis was present and were not acquired as part of colonization studies. Respiratory isolates from patients were cross-referenced in the database to identify cases where a positive conjunctival swab was also present. The isolated microorganisms and their sensitivity patterns were subsequently compared. Patient medical records were scrutinized, with age and underlying infections documented. To be included in this retrospective study, patients had to have both samples collected during the same clinical episode

The study complies with the postulates of Helsinki´s Declaration. No human biological material or identifiable human data were used, therefore ethical approval was exempted

RESULTS

The median age of the patients was 5 months (range 0.5-22). Twenty-one patients had both positive bronchial aspirate and conjunctival swab results. However, in three out of these 21 cases, the microorganisms isolated from the bronchial aspirate and conjunctival swab did not match. The details of the isolated microorganisms and sampling dates for both types of samples are presented in Table 1. In the remaining 18 cases, the microorganisms isolated from the bronchial aspirate matched with those isolated in the conjunctival swab, and vice versa. The susceptibility profiles of the isolated microorganisms were also the same in these cases. The coincidence in the isolated microorganisms from both samples in this cohort was 85.71% (18 out of 21). In only three patients, the isolated microorganisms differed in both samples (14.29%). It is worth noting that in two out of these three cases, the samples were collected more than three weeks apart. The most frequently isolated microorganisms were H. influenzae (55.6%, 10 out of 21 isolates), followed by P. aeruginosa (14.3%, 3 out of 21 isolates), K. aerogenes (9.5%, 2 out of 21 isolates) and E.cloacae, S.maltophilia and E.coli with 4.8% of the isolates (1 out of 21 isolates). Notably, Pseudomonas aeruginosa and Enterobacterales isolates are associated with nosocomial respiratory infections, including ventilator-associated pneumonia or tracheobronchitis, and aspirative pneumonia. H. influenzae isolates are commonly associated with bacterial superinfections in patients with active viral infections

Table 1.

Age, samples and microorganisms isolated in each patient

Patient* Age BAS microorganism isolated Conjunctival microorganism isolated Difference in days between the two samples Antimicrobial resistance features Respiratory infection
1 1 month H. influenzae H. influenzae 17 Positive betalactamase. Same susceptibility pattern RSV + bacterial superinfection
2 3 months P. aeruginosa P. aeruginosa Same day Same susceptibility pattern Hospital acquired respiratory infection
3 6 months K. pneumoniae H. influenzae 50 Not the same microorganisms Hospital acquired respiratory infection
4 12 months H. influenzae H. influenzae 1 Negative betalactamase. Same susceptibility pattern RSV + bacterial superinfection
5 7 months H. influenzae H. influenzae Same day Negative betalactamase Ventilator associated pneumonia (VAP)
6 22 months P. aeruginosa H. influenzae 28 Not the same microorganisms Aspirative pneumonia
7 1 month H. influenzae H. influenzae Same day Negative betalactamase. Same susceptibility pattern RSV + bacterial superinfection
8 15 days H. influenzae H. influenzae Same day Negative betalactamase. Same susceptibility pattern RSV + bacterial superinfection
9 16 days H. influenzae H. influenzae Same day Negative betalactamase. Same susceptibility pattern RSV+ bacterial superinfection
10 2 months H. influenzae H. influenzae 1 Negative betalactamase. Same susceptibility pattern Pertussis and bacterial superinfection
11 15 days H. influenzae H. influenzae 1 Negative betalactamase. Same susceptibility pattern Rhinovirus + bacterial superinfection
12 5 months E. coli E. coli 3 Same susceptibility pattern Tracheobronchitis associated to mechanical ventilation
13 1 month P. aeruginosa+ S. marcescens S. aureus Same day Not the same microorganisms RSV + bacterial superinfection
14 6 months K. aerogenes K. aerogenes 2 Same susceptibility pattern Ventilator associated pneumonia
15 1 month H. influenzae H. influenzae. Same day Negative betalactamase. Same susceptibility pattern Metapneumovirus + bacterial superinfection
16 17 months P. aeruginosa VIM P. aeruginosa 39 Rectal colonization with
P. aeruginosa VIM
Nosocomial respiratory infection
17 13 months K. aerogenes K. aerogenes 2 Same susceptibility pattern Hospital acquired respiratory infection
18 8 months P. aeruginosa P. aeruginosa 10 Same susceptibility pattern Hospital acquired respiratory infection
19 6 months E. cloacae E. cloacae 7 Same susceptibility pattern Aspirative pneumonia
20 6 months S. maltophilia S. maltophilia 1 Same susceptibility pattern Hospital acquired respiratory infection
21 3 months H. influenzae H. influenzae Same day Negative betalactamase. Same susceptibility pattern RSV + bacterial superinfection
*

The years have been avoided to ensure the anonymity of the samples and the patients. BAS: Bronchial aspirates, RSV: Respiratory syncitial virus

DISCUSSION

H. influenzae, M. catarrhalis, and S. pneumoniae are common colonizers of the oropharynx and can also cause bacterial conjunctivitis and otitis by spreading from the respiratory tract to the ear and conjunctiva [2]. Additionally, Enterobacterales, S. aureus, P. aeruginosa, and A. baumannii are pathogens causing HAP, the most common infection in the intensive care unit (ICU) [6]. These microorganisms can also cause hospital-acquired conjunctivitis. Although in our study we did not analyze viral conjunctival infections, viruses such as RSV and SARS-CoV-2 can cause conjunctivitis, albeit less frequently. For instance, in the study conducted by Wrotek et al. [7], focusing on the prevalence of complications in hospitalized children due to RSV, among 111 children examined, 12 also presented with conjunctivitis. Regarding COVID-19, a meta-analysis published by Nasiri et al. [8] revealed that among 7300 patients with COVID-19, the pooled prevalence of ocular manifestations was 11.03%, with conjunctivitis being the most prevalent ocular condition (88.8%)

In our observational study, we searched for patients admitted to the PICU who underwent sampling of bronchial aspirate and conjunctival swabs. We collected patients with positive cultures for significant microorganisms, as described above. We observed an 85.7% agreement between the micro-organisms isolated in both types of samples

Given the high degree of concordance between micro-organisms in both types of samples, we question whether the conjunctival swab could be useful in predicting which microorganism is causing the respiratory infection. There is currently no scientific evidence on the usefulness of the conjunctival swab for this purpose. However, there are manuscripts describing the usefulness of the methicillin-resistant S. aureus (MRSA) nares screening (MNS) to help limit empiric anti-MRSA antibiotic therapy in both children and adults [9,10]. The specificity and the negative predictive value of the MNS to predict a clinical MRSA infection were both 95.5% and it has proven to be useful for limiting unnecessary anti-MRSA therapy, making it a useful antimicrobial stewardship tool for hospitalized children [9]. Additionally, rectal colonization studies for the detection of carbapenemase-producing microorganisms appear to be useful in predicting sepsis caused by these microorganisms. Colonized patients are more likely to develop bacteremia due to these micro-organisms than those who are not colonized [11]. Therefore, a prospective study to corroborate our observation is mandatory. The conjunctival swab could be useful in predicting the microorganism that is causing the respiratory infection if similar results are obtained. This prospective study should be designed without the limitations of our retrospective study, including a small number of patients and patients with a conjunctival swab who had clinical conjunctivitis rather than being included as part of colonization studies. Therefore, conjunctival swabs should be taken as part of colonization studies without clinical symptoms to determine whether there is a coincidence with the microorganisms isolated in respiratory specimens

In conclusion, we observed a high coincidence between the microorganisms isolated in both types of samples. These results provide the basis for future prospective studies to evaluate the conjunctival swab as a tool for predicting the microorganisms that are causing respiratory infection. The usefulness of the conjunctival swab in the identification of microorganisms causing respiratory pathology in children should be tested. The conjunctival swab could have potential use as a tool for antimicrobial stewardship programs in patients with respiratory bacterial infection or superinfection for adjustment of antibiotic therapy in cases where bronchial aspirate or respiratory samples cannot be obtained

FUNDING

None to declare

CONFLICTS OF INTEREST

The authors declare no conflicts of interest.

References

  • 1.Hu YL, Lee PI, Hsueh PR, et al. Predominant role of Haemophilus influenzae in the association of conjunctivitis, acute otitis media and acute bacterial paranasal sinusitis in children. Sci Rep 2021; 11. 2021. Jan 8;11(1):11 10.1038/s41598-020-79680-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Teweldemedhin M, Gebreyesus H, Atsbaha AH, Asgedom SW, Saravanan M. Bacterial profile of ocular infections: a systematic review. BMC Ophthalmol 2017; 17(1):212 10.1186/s12886-017-0612-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hedberg P, Johansson N, Ternhag A, Abdel-Halim L, Hedlund J, Nauclér P. Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus. BMC Infect Dis 2022; 22(1):108 10.1186/s12879-022-07089-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Lin HC, Liu YC, Hsing TY, et al. RSV pneumonia with or without bacterial co-infection among healthy children. J Formos Med Assoc 2022; 121(3):687-693 10.1016/j.jfma.2021.08.012 [DOI] [PubMed] [Google Scholar]
  • 5.Hishiki H, Ishiwada N, Fukasawa C, et al. Incidence of bacterial coinfection with respiratory syncytial virus bronchopulmonary infection in pediatric inpatients. J Infect Chemother 2011; 17(1):87-90 10.1007/s10156-010-0097-x [DOI] [PubMed] [Google Scholar]
  • 6.Leone M, Bouadma L, Bouhemad B, et al. Hospital-acquired pneumonia in ICU. Anaesth Crit Care Pain Med 2018; 37(1):83-98 10.1016/j.accpm.2017.11.006 [DOI] [PubMed] [Google Scholar]
  • 7.Wrotek A, Kobiałka M, Grochowski B, Kamińska I, P ędziwiatr K, Skoczek-Wojciechowska A, Godek M, Jackowska T. Respiratory Complications in Children Hospitalized with Respiratory Syncytial Virus Infection. Adv Exp Med Biol. 2020;1279:113-120. 10.1007/5584_2020_530 [DOI] [PubMed] [Google Scholar]
  • 8.Nasiri N, Sharifi H, Bazrafshan A, Noori A, Karamouzian M, Sharifi A. Ocular Manifestations of COVID-19: A Systematic Review and Meta-analysis. J Ophthalmic Vis Res. 2021. Jan 20;16(1):103-112 10.18502/jovr.v16i1.8256 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sands A, Mulvey N, Iacono D, Cerise J, Hagmann SHF. Utility of Methicillin-Resistant Staphylococcus aureus Nares Screening in Hospitalized Children with Acute Infectious Disease Syndromes. Antibiotics (Basel) 2021; 10(12):1434 10.3390/antibiotics10121434 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Parente DM, Cunha CB, Mylonakis E, Timbrook TT. The Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis With Antimicrobial Stewardship Implications. Clin Infect Dis 2018; 67(1):1-7 10.1093/cid/ciy024 [DOI] [PubMed] [Google Scholar]
  • 11.Ara-Montojo MF, Escosa-García L, Alguacil-Guillén M, et al. Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children. J Antimicrob Chem-other 2021; 76(1):220-225 10.1093/jac/dkaa397 [DOI] [PubMed] [Google Scholar]

Articles from Revista Española de Quimioterapia are provided here courtesy of Sociedad Española de Quimioterapia

RESOURCES